Emcure Pharmaceuticals Ltd. IPO

Emcure Pharmaceuticals Limited is a leading Indian pharmaceutical company known for its research and development. They offer a wide range of medications across various therapeutic areas, including gynecology and HIV/AIDS antivirals where they hold the top spot in India. They are rapidly growing with a strong presence in over 70 countries, particularly India, Europe, and Canada. Their focus on chronic illnesses positions them well for future growth in the Indian market.

RHP
View
DRHP
View
Open Date

2024-07-03

Close Date

2024-07-05

IPO Details

Check out the issue details for Emcure Pharmaceuticals Ltd. IPO as disclosed in SEBI.

Price Band

₹ 960 - 1008

Issue Size

1952.03 Cr.

Issue Type

Book Built

Open

2024-07-03

Close

2024-07-05

Listing Date

2024-07-10

Company Financials

You can get the following financial statements of Emcure Pharmaceuticals Ltd. as of now.

Subscription Details

The details about the Emcure Pharmaceuticals Limited IPO is as:

  • The issue size of the Emcure Pharmaceuticals Limited IPO is 1952.03 Cr.
  • The price band for Emcure Pharmaceuticals Limited IPO is Rs 960 to Rs 1008.
  • The shares of Emcure Pharmaceuticals Limited IPO will list on 10th July 2024.
  • The latest tentative GMP of Emcure Pharmaceuticals Limited IPO is Rs 295.
  • The shares of Emcure Pharmaceuticals Limited IPO is subscribed 1.32 Times as of 3rd July 2024. 

 

Emcure Pharmaceuticals Limited IPO Valuation

The approx valuation of Emcure Pharmaceuticals Limited IPO based on its price band and DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 1008
Existing Shares (Qty) 18.11 Cr
Fresh Issue 800 Cr
Market Cap 19,054.88 Cr
EPS (FY24) Rs 27.54
PE Ratio 36.60x
Industry PE 40.41x

 

Emcure Pharmaceuticals Limited IPO Issue Size

Emcure Pharmaceuticals Limited IPO issue size is 1952.03 Cr

Issue Amount
Fresh Issue 800 Cr
Offer For Sale 1152.03 Cr

 

Emcure Pharmaceuticals Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 14 shares and a maximum of 14 lots of 196 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 14 14,112
 Maximum 14 196 1,97,568

 

Emcure Pharmaceuticals Limited IPO share offer

The shares of Emcure Pharmaceuticals Limited IPO is subscribed 1.32 Times as of 3rd July 2024. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 0.07 Times
Non-Institutional Minimum 15% 2.76 Times
Retail Individual Minimum 35% 1.41 Times
Employee 1,08,900 Shares 2.25 Times
Total   1.32 Times

Allotment Details

Find below the dates for Emcure Pharmaceuticals Limited IPO:

Schedule Date
Basis of Allotment 8 July 2024
Refunds 9 July 2024
Credit to Demat Account 9 July 2024
IPO Listing Date 10 July 2024

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 2453.7 2375.71 3153.66 3387.24 3107.09
Total Expenditure 1883.3 1952.29 2410.26 2592.57 2668.59
Operating Profit 570.41 423.42 743.41 794.67 438.49
Other Income 90.88 137.62 111.91 132.68 125.35
Interest 126.65 137.22 123.34 145.14 166.83
Depreciation 129.84 154.97 156.24 165.79 178.52
Exceptional Items -34.96 -44.16 -18.29 0 -6.15
Profit Before Tax 369.84 224.68 557.45 616.42 212.34
Provision for Tax 86.18 49.48 136.97 169.61 52.28
Net Profit 283.65 175.21 420.48 446.81 160.06
Adjusted EPS (Rs.) 1.57 0.97 2.32 2.47 0.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 180.85 180.85 180.85 180.85 180.85
Total Reserves 1596.66 1733.7 2120.92 1531.68 1661.02
Borrowings 442.39 453.87 645.97 512.4 600.65
Other N/C liabilities 84.35 123 126.27 164.19 177
Current liabilities 1273.33 1379.78 1789.18 1934.06 1996.33
Total Liabilities 3577.57 3871.2 4863.2 4323.18 4615.85
Assets
Net Block 1099.92 1166.06 1277.9 1307.36 1432.71
Capital WIP 405.96 326.06 192.09 239.25 253.1
Intangible WIP 0 0 0 0 0
Investments 310.57 407.71 863.73 563.36 690.02
Loans & Advances 101.81 138.23 299.42 63.25 77.51
Other N/C Assets 21.01 25.58 14.6 13.92 23.01
Current Assets 1638.3 1807.57 2215.46 2136.05 2139.51
Total Assets 3577.57 3871.2 4863.2 4323.18 4615.85
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023
Profit from operations 616.42 212.34
Adjustment 265 309.21
Changes in Assets & Liabilities -283.04 68.37
Tax Paid -170.67 -84.54
Operating Cash Flow 427.71 505.37
Investing Cash Flow -393.81 -270.56
Financing Cash Flow -342.96 -54.52
Net Cash Flow -309.06 180.3
X